Perritt Capital Management Inc Abb Vie Inc. Transaction History

Perritt Capital Management Inc

$185 Million
Q3 2024

A detailed history of Perritt Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Perritt Capital Management Inc holds 5,006 shares of ABBV stock, worth $878,953. This represents 0.53% of its overall portfolio holdings.

Number of Shares

5,006

Previous 5,072 1.3%

Holding current value

$878,953

Previous $869,000 13.69%

% of portfolio

0.53%

Previous 0.5%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $10,813 - $13,155	-66 Reduced 1.3%	5,006 $988,000
Q2 2024 Aug 07, 2024	SELL	$154.79 - $180.76 $13,931 - $16,268	-90 Reduced 1.74%	5,072 $869,000
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $1,118 - $1,274	7 Added 0.14%	5,162 $940,000
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $127,280 - $143,347	-925 Reduced 15.21%	5,155 $798,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $68,507 - $85,253	-517 Reduced 7.84%	6,080 $819,000
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $42,081 - $48,463	-291 Reduced 4.22%	6,597 $1.05 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $4,564 - $5,473	-33 Reduced 0.48%	6,888 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $7,247 - $8,312	-54 Reduced 0.77%	6,921 $929,000
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $20,643 - $26,244	-150 Reduced 2.11%	6,975 $1.07 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $102,680 - $127,397	-778 Reduced 9.84%	7,125 $1.16 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $5,908 - $7,476	55 Added 0.7%	7,903 $1.07 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $48,944 - $55,558	460 Added 6.23%	7,848 $847,000
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $192,534 - $214,494	1,830 Added 32.93%	7,388 $832,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $22,506 - $24,776	220 Added 4.12%	5,558 $601,000
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $24,147 - $32,601	-300 Reduced 5.32%	5,338 $572,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $41,924 - $49,205	-488 Reduced 7.97%	5,638 $494,000
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $117,392 - $157,088	-1,600 Reduced 20.71%	6,126 $601,000
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $1,574 - $1,893	-25 Reduced 0.32%	7,726 $585,000
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $1,642 - $2,099	25 Added 0.32%	7,751 $625,000
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $1,642 - $2,099	-25 Reduced 0.32%	7,726 $562,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $3,857 - $4,539	-50 Reduced 0.64%	7,751 $625,000
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $13,623 - $16,801	-175 Reduced 2.19%	7,801 $719,000
Q4 2017 Jan 25, 2018	SELL	$89.56 - $98.21 $8,956 - $9,821	-100 Reduced 1.24%	7,976 $771,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $564,108 - $720,540	8,076	8,076 $718,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.

Account

Perritt Capital Management Inc Abb Vie Inc. Transaction History